Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Teva Settles With Pfizer Over Xeljanz XR As 2025 Date Looms
Israeli Firm Previously Sued Over Patent Expiring In 2034
Sep 09 2021
•
By
Dean Rudge
Teva was sued by Pfizer at the end of 2018 • Source: Alamy
More from Generics
More from Products